About
DNA Vaccine
Areas of Focus
Categories
Gene Therapy, RNA & Peptide Therapy
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
257
By Phase
PHASE1/PHASE2: 2PHASE1: 2PHASE2: 1
By Status
COMPLETED: 3RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT05672459Collaborator
A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors
PHASE1/PHASE2Recruiting
117 participants
Started: Jun 21, 2023 · Completed: Dec 29, 2029
NCT04515043Lead Sponsor
EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754)
PHASE1Completed
6 participants
Started: Oct 16, 2020 · Completed: Dec 19, 2020
NCT03265717Lead Sponsor
DNA Plasmid Encoding a Modified Human Telomerase Reverse Transcriptase (hTERT), Invac-1 in Chronic Lymphocytic Leukemia
PHASE2Terminated
26 participants
Started: Jul 25, 2018 · Completed: Jun 30, 2020
NCT02818426Collaborator
Universal Cancer Peptide-based Vaccination in Metastatic NSCLC
PHASE1/PHASE2Completed
82 participants
Started: Apr 20, 2016 · Completed: Dec 31, 2024
NCT02301754Lead Sponsor
INVAC-1 Anti-Cancer hTERT DNA Immunotherapy
PHASE1Completed
26 participants
Started: Nov 30, 2014 · Completed: Jun 1, 2018
Locations (1)
Headquarters
Paris, France
Map
Loading map...